يعرض 861 - 880 نتائج من 3,171 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant ((all decrease) OR (a decrease)) ))~', وقت الاستعلام: 0.36s تنقيح النتائج
  1. 861
  2. 862
  3. 863

    Effect of ibuprofen (IBU) on HIF-1α transcriptional activity and protein level. حسب Katarina Grossmannova (7543517)

    منشور في 2025
    "…(C) Detection of HIF-1α protein by Western blot showed that IBU downregulated HIF-1α protein level in a time- and dose-dependent manner in all four analyzed cell lines incubated in monolayer in hypoxia. …"
  4. 864

    Table 2_L-shaped association between triglyceride-glucose body mass index and short-term mortality in ICU patients with sepsis-associated acute kidney injury.docx حسب Heping Xu (95297)

    منشور في 2024
    "…Higher TyG-BMI values were significantly associated with reduced short-term mortality rates (28, 90, and 180 days) in patients with SA-AKI; for each standard deviation increase in TyG-BMI, the risk of all-cause death decreased by 0.2% (p < 0.0001). …"
  5. 865

    Table 1_L-shaped association between triglyceride-glucose body mass index and short-term mortality in ICU patients with sepsis-associated acute kidney injury.docx حسب Heping Xu (95297)

    منشور في 2024
    "…Higher TyG-BMI values were significantly associated with reduced short-term mortality rates (28, 90, and 180 days) in patients with SA-AKI; for each standard deviation increase in TyG-BMI, the risk of all-cause death decreased by 0.2% (p < 0.0001). …"
  6. 866

    Image 3_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff حسب Qianyi Zhou (6196383)

    منشور في 2025
    "…Purpose<p>CD19 chimeric antigen receptor T (CAR-T) cell therapy has shown promise in treating relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), but cytokine release syndrome (CRS) remains a significant side effect.…"
  7. 867

    Table 1_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.docx حسب Qianyi Zhou (6196383)

    منشور في 2025
    "…Purpose<p>CD19 chimeric antigen receptor T (CAR-T) cell therapy has shown promise in treating relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), but cytokine release syndrome (CRS) remains a significant side effect.…"
  8. 868

    Image 2_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff حسب Qianyi Zhou (6196383)

    منشور في 2025
    "…Purpose<p>CD19 chimeric antigen receptor T (CAR-T) cell therapy has shown promise in treating relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), but cytokine release syndrome (CRS) remains a significant side effect.…"
  9. 869

    Table 2_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.doc حسب Qianyi Zhou (6196383)

    منشور في 2025
    "…Purpose<p>CD19 chimeric antigen receptor T (CAR-T) cell therapy has shown promise in treating relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), but cytokine release syndrome (CRS) remains a significant side effect.…"
  10. 870

    Image 1_Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.tiff حسب Qianyi Zhou (6196383)

    منشور في 2025
    "…Purpose<p>CD19 chimeric antigen receptor T (CAR-T) cell therapy has shown promise in treating relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), but cytokine release syndrome (CRS) remains a significant side effect.…"
  11. 871
  12. 872

    The original plotting data for Fig 7. حسب Haoxuan Xue (19949764)

    منشور في 2024
    "…There were significant correlations among NF-κB-related inflammatory factors, TERT and apoptotic factors, and they were positively correlated with Bax and Caspase-3, and negatively correlated with Bcl-2 (<i>P</i> are all less than 0.05). …"
  13. 873

    Primer sequences used for the qRT-PCR analysis. حسب Haoxuan Xue (19949764)

    منشور في 2024
    "…There were significant correlations among NF-κB-related inflammatory factors, TERT and apoptotic factors, and they were positively correlated with Bax and Caspase-3, and negatively correlated with Bcl-2 (<i>P</i> are all less than 0.05). …"
  14. 874
  15. 875

    Grid independence test. حسب Zhen Zhao (159931)

    منشور في 2025
    "…The results indicate that schemes 1, 2, and 4 all have significant low-speed vortices in the return water zone (D zone). …"
  16. 876

    Physical picture of flow channel of emitter. حسب Zhen Zhao (159931)

    منشور في 2025
    "…The results indicate that schemes 1, 2, and 4 all have significant low-speed vortices in the return water zone (D zone). …"
  17. 877

    The test results of relative flow of emitters. حسب Zhen Zhao (159931)

    منشور في 2025
    "…The results indicate that schemes 1, 2, and 4 all have significant low-speed vortices in the return water zone (D zone). …"
  18. 878

    The details of flow chart. حسب Zhen Zhao (159931)

    منشور في 2025
    "…The results indicate that schemes 1, 2, and 4 all have significant low-speed vortices in the return water zone (D zone). …"
  19. 879

    The physical short-period clogging test device. حسب Zhen Zhao (159931)

    منشور في 2025
    "…The results indicate that schemes 1, 2, and 4 all have significant low-speed vortices in the return water zone (D zone). …"
  20. 880

    Characteristics of Study Participants. حسب Alix Boisson-Walsh (17847176)

    منشور في 2025
    "…We observed statistically significant declines across all five vaccine confidence domains when comparing responses before and during the pandemic (<i>p</i> < 0.01): vaccines prevent diseases (85.4%-68.3%), are safe (80.5%-46.3%), important for a child’s health (92.7%-87.8%) and one’s own health (87.8%-68.3%), and new vaccines carry no more risk than routine vaccines (78.1%-63.5%). …"